Medication Non-Adherence in Diabetes: A Look at Costs
Oral medications and insulin are cornerstones of diabetes management, but as many as one-third of...
glycemic control
Diabetes & Fracture Hospitalization Risk
Published research has indicated that people with type 2 diabetes are at increased risk for bone...
Group Education & Older Diabetics
Studies suggest that group-based diabetes education efforts can improve short- and long-term...
Managing Cognitive Decline in Older Adults With Diabetes
This Physician’s Weekly feature on managing cognitive decline in older adults with diabetes was completed in cooperation with the experts at the American Diabetes Association. More than 25% of Americans aged 65 and older has...
Glycemic Control After Surgery in Kids
Tight glycemic control appears to be achievable following cardiac surgery in children ages 0 to 36 months, with low rates of hypoglycemia, according to a randomized, control trial. The researchers noted, however, that tight...
Goal Setting for Older Adults With Diabetes
To successfully manage type 2 diabetes in older adults, clinicians must recognize and understand the unique challenges these individuals face. While the benefits of tight glycemic control in older adults are similar to those of...
Transitioning From Pediatric to Adult Diabetes Care
This Physician’s Weekly feature covering the transitioning from pediatric to adult diabetes care was completed in cooperation with the experts at the American Diabetes Association. During childhood and adolescence, diabetes care...
New Guidelines for Managing Hyperglycemia in Type 2 Diabetes
[sam id=”4″ codes=”true”]In recent years, more pharmacologic agents and...
Structuring Behavioral Interventions for Diabetes
Approximately 45% of patients with diabetes have not achieved an A1C level of less than 7%. Studies show that improved glycemia helps delay or prevent serious diabetes complications. However, poor adherence to medication...
Controlling Glucose: Mobile Apps to the Rescue
In the United States, diabetes affects 25.8 million people, for whom the costs of care exceed $100 billion annually. Clinical trials suggest that improved self-care and lifestyle changes can lead to better diabetes-related...
A Once-Weekly Diabetes Medication
Exenatide extended-release for injectable suspension (Bydureon, Amylin) has been approved by the FDA as a once-weekly treatment for type 2 diabetes. The glucagon-like peptide-1 receptor agonist is indicated as an adjunct to diet...
Strategies for Improving Diabetes Care
This Physician’s Weekly feature was completed in cooperation with the experts at the American Diabetes Association. Over the last decade, healthcare providers in primary care settings and endocrinology practices have seen...
